We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Smartphone-Controlled Microfluidic Device Enables Rapid Influenza Detection

By LabMedica International staff writers
Posted on 15 Jul 2024
Print article
Image: Schematic illustration of the SEDphone system workflow (Photo courtesy of ZHU Cancan)
Image: Schematic illustration of the SEDphone system workflow (Photo courtesy of ZHU Cancan)

The influenza virus represents a significant public health concern, annually causing epidemics with high morbidity and mortality rates. The virus is known for its high mutation rate and the existence of multiple subtypes, which require varied clinical approaches. Consequently, there is a critical need for an accurate, rapid, and portable method to differentiate between influenza virus subtypes to manage virus transmission and inform clinical treatment decisions. Researchers have now developed a spatial encoding of a centrifugal microfluidic disc-integrated smartphone-controlled (SEDphone) platform for detecting influenza virus subtypes.

In a study, researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (Anhui, China) developed a novel approach that combines Loop-mediated Isothermal Amplification (LAMP) with CRISPR/Cas12a technologies for rapid and accurate detection of various influenza viruses. This method amplifies target sequences using LAMP and detects them through CRISPR/Cas12a-mediated trans-cleavage activity, thus cleaving reporter probes and emitting fluorescent signals. This technique is highly sensitive and reduces the occurrence of false positives. To aid the detection of different influenza strains, the researchers devised a flexible model capable of targeting multiple flu types. Following optimization, this method can identify five influenza types (H1N1, H3N2, H5N1, H7N9, and Influenza B) within 45 minutes, even at low viral concentrations (10 copies/μL).

Furthermore, to facilitate simultaneous LAMP amplification and CRISPR detection, the team engineered a centrifugal microfluidic chip with spatial encoding features. They also developed a portable testing device, dubbed SEDphone, which operates via smartphone control. This device can simultaneously amplify and detect multiple influenza virus types. Incorporating a dual temperature zone design, it addresses the temperature variance required for both technologies. Clinical sample testing confirmed that this innovative method and the SEDphone device are effective in rapidly identifying various influenza subtypes. The research results were published in Sensors and Actuators: B. Chemical.

"Our research offers a new way to quickly and accurately detect various pathogens in real-time. This method can be used in fever clinics or at home, helping to reduce the risk of unnecessary cross-infection and easing the burden on healthcare systems," said Dr. ZHU Cancan, a member of the research team.

Related Links:
Hefei Institutes of Physical Science

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
New
Silver Member
CEA Assay
Carcinoembryonic Antigen Assay
New
RNA Isolation Kits
RNeasy Plus Kits for RNA Isolation

Print article

Channels

Immunology

view channel
Image: The blood test for fungal infections provides faster results and has a less invasive process (Photo courtesy of 123RF)

Blood Test for Fungal Infections Could End Invasive Tissue Biopsies

For individuals with weakened immune systems, common molds found in the environment—such as in the soil, on damp walls, or on forgotten fruits—can lead to severe infections deep within the body.... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: The plasma cell dataset was created to assist in the accurate diagnosis (Photo courtesy of Shutterstock)

Novel Dataset of Plasma Cells to Aid Diagnosis of Multiple Myeloma

Myeloma is a rare blood cancer that originates in plasma cells, a type of immune cell responsible for producing antibodies that help fight infections. The disease begins when an abnormal plasma cell starts... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.